Mark Cuban has called for significant reform in the pharmaceutical industry, emphasizing the need to dismantle large insurance companies that prioritize profits over consumer needs. This statement came during a panel discussion with U.S. Medicare Director Chris Klomp at the Silicon Slopes Summit in Salt Lake City on March 15, 2024. The conversation was particularly relevant as it coincided with the launch of TrumpRX, a new low-cost drug website introduced by former President Donald Trump.
TrumpRX aims to reduce prices for 43 brand-name medications, which Trump claims will have “a real and immediate impact” on the market. Notably, the prices listed on TrumpRX are lower than those on competing sites such as GoodRX. However, the platform does not offer generic options, and all transactions must be completed in cash without insurance coverage. While more drugs are expected to join the TrumpRX catalog, the current selection is modest when compared to the more than 6,000 medications available on Cuban’s own platform, Cost Plus Drugs. Cuban’s site focuses on generic alternatives, with prices typically ranging from $6 to $12 compared to up to $200 for brand-name medications.
Cuban remarked, “I’m a supporter of TrumpRX, but they reduce brand prices by 500 percent or 1,000 percent, while ‘CubanRX’ reduces prices by 1,500 percent.” This comment was delivered in a light-hearted manner, referencing Trump’s penchant for making bold claims about price reductions. Cuban further asserted that Cost Plus Drugs is cheaper on 90 percent of the drugs both platforms carry. He acknowledged the success of TrumpRX in pricing IVF drugs competitively, which he noted could be a lifesaver for many couples seeking fertility treatment.
Klomp shared a personal connection to the issue, revealing that his mother died of cancer when he was just 13 years old. He emphasized the pressing need for legislative action to ensure lower prices for a broader range of medications, noting that approximately 65 percent of Americans live with a chronic disease and 75 percent are classified as overweight. “We are objectively the least healthy we have ever been as a country,” Klomp stated.
Cuban criticized the slow pace of Congress, advocating for immediate consumer relief. His proposed solutions include breaking up large pharmaceutical companies, mandating that drug manufacturers sell at net prices to wholesalers, establishing Medicare rates, and guaranteeing deductibles for low-income individuals.
Both Cuban and Klomp concluded their discussion by urging attendees to focus on making positive contributions to society that extend beyond financial gain. Klomp advised, “Don’t waste your time on things that don’t make the world better. Alleviate human suffering.”
As the conversation around drug pricing continues to evolve, the effectiveness of platforms like TrumpRX and Cost Plus Drugs will play a critical role in shaping consumer experiences and expectations in the pharmaceutical market.
The final deadline for applications for the 2026 Inc. Best Workplaces awards is set for February 20 at 11:59 p.m. PT. Interested parties can apply through the official website.
